CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Digital Health (6540) Genomics (615)
Accuragen has developed a high-sensitivity next-generation sequencing-based system for the detection of cancer mutations in minuscule concentrations of circulating cell-free DNA (cfDNA) in blood. The Company's technology addresses the significant bar...Show all
Company (Alive / Active)
Phone: 650-618-5028
1455 Adams Drive
Suite 1015
Menlo Park, 94025
California, United States
| Total Funding | Date of Last Funding | |
|---|---|---|
| Accuragen | $47.2M | Apr 15, 2020 |
| See all 5 competitors | ||
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Company | Status | Description | Investors |
|---|---|---|---|
| Rockville, Maryland, United States | Alive / Active | 20/20 GeneSystems has developed, validated, and undergone clinical testing of a blood test for the early detection of lung cancer. The test measures a panel of tumor biomarkers and utilizes a proprietary algorithm to combine the biomarker values to generate a unitary risk score. | Login to see details |
| San Diego, California, United States | IPO / Went public | Biocept is a molecular oncology diagnostics company specializing in Circulating Tumor Cells (CTCs) and biomarker analysis, headquartered in San Diego, California. The company's mission is to improve outcomes for cancer patients by advancing oncology diagnostics. Biocept utilizes patented and innovative technologies to deliver clinically relevant oncology diagnostics to physicians by providing advanced prognostic and predictive assessments for guiding the course of treating patients. Additionally...Show all | Login to see details |
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Compositions and methods for detecting rare sequence variants | Dec 11, 2014 | Sep 08, 2020 | Patent |
| Methods and compositions for enrichment of amplification products | Apr 06, 2018 | Aug 25, 2020 | Patent |
| Compositions and methods for detecting rare sequence variants | Oct 26, 2018 | Jul 28, 2020 | Patent |
| Compositions and methods for detecting rare sequence variants | Nov 01, 2017 | Dec 18, 2018 | Patent |
| Compositions and methods for detecting rare sequence variants | Jul 31, 2020 | Application |
